Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Increased Efficacy of Chemomobilization with Intermediate Dose Cytarabine + G-CSF Compared to G-CSF Alone for Patients with Multiple Myeloma: Results of a Prospective, Randomized Trial

Tomasz Czerw, Wlodzimierz Mendrek, Jacek Najda, Malgorzata Sobczyk-Kruszelnicka, Maria Sadus-Wojciechowska, Katarzyna Soska, Magdalena Glowala-Kosinska, Agata Chwieduk, Wojciech Fidyk, Jerzy Holowiecki, MD PhD, Sebastian Giebel

Blood (2016) 128 (22): 656.

https://doi.org/10.1182/blood.V128.22.656.656

Published: 2016

Journal Articles

Cladribine, Cytarabine and Mitoxantrone As Treatment Intensification for Patients with Acute Myeloid Leukemia with the Excess of Bone Marrow Blasts on Day 14 of the First Induction. Prospective, Multicenter Study By the Polish Adult Leukemia Group (PALG)

Blood (2016) 128 (22): 213.

https://doi.org/10.1182/blood.V128.22.213.213

Published: 2016

Journal Articles

Cladribine Added to Daunorubicin and Cytarabine Induction Regimen Prolongs Survival of Patients with Complex but Not Monosomal Karyotype Acute Myeloid Leukemia – Retrospective Analysis of Polish Adult Leukemia Group (PALG)

Blood (2014) 124 (21): 2347.

https://doi.org/10.1182/blood.V124.21.2347.2347

Published: 2014

Journal Articles

The Aethera Trial: Results of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Brentuximab Vedotin in the Treatment of Patients at Risk of Progression Following Autologous Stem Cell Transplant for Hodgkin Lymphoma

Craig H. Moskowitz, MD, Auayporn Nadamanee, MD, Tamas Masszi, MD PhD, Edward Agura, MD, Jerzy Holowiecki, MD PhD, Muneer H. Abidi, MD, Andy I Chen, MDPhD, Patrick J. Stiff, MD, Alessandro M. Gianni, MD, Angelo M. Carella, MD, Dzhelil Osmanov, MD, Veronika Bachanova, MD, John Sweetenham, MD, Anna Sureda, Dirk Huebner, MD, Emily K. Larsen, MS, Naomi N.H. Hunder, MD, Jan Walewski

Blood (2014) 124 (21): 673.

https://doi.org/10.1182/blood.V124.21.673.673

Published: 2014

Journal Articles

Daunorubicine, Cytarabine and Cladribine (DAC) Vs Daunorubicine and Cytarabine (DA) Induction Treatment in Elderly Acute Myeloid Leukemia (AML) Patients – Results of the Prospective, Multicenter, Randomized Trial of the Polish Adult Leukemia Group (PALG)

Blood (2012) 120 (21): 3602.

https://doi.org/10.1182/blood.V120.21.3602.3602

Published: 2012

Journal Articles

Autologous Peripheral Blood Progenitor Cells Cryopreserved in 7.5% DMSO Give Faster Hematopoietic Reconstitution Than Cells Cryopreserved in 10% DMSO.

Iwona Mitrus, PhD, Andrzej Smagur, PhD, Sebastian Giebel, MD, Joanna Gliwinska, Magdalena Prokop, Agata Chwieduk, PhD, Magdalena Glowala-Kosinska, PhD, Maria Sadus-Wojciechowska, MD, Jerzy Holowiecki, MD, PhD

Blood (2012) 120 (21): 3018.

https://doi.org/10.1182/blood.V120.21.3018.3018

Published: 2012

Journal Articles

Very High Efficacy of Stem Cell Mobilization Using Intermadiate-Dose Cytosine Arabinoside + G-CSF in Patients with Lymphoid Malignancies, Including Predicted and Proven Poor Mobilizers

Tomasz Kruzel, Tomasz Czerw, MD, Maria Sadus-Wojciechowska, MD, Jacek Najda, MD, Magdalena Glowala-Kosinska, PhD, Agata Chwieduk, PhD, Iwona Mitrus, PhD, Andrzej Smagur, PhD, Jerzy Holowiecki, MD, PhD, Sebastian Giebel, MD

Blood (2012) 120 (21): 4131.

https://doi.org/10.1182/blood.V120.21.4131.4131

Published: 2012

Journal Articles

Is Type of Monosomy (Total or Partial) Crucial for Prognostic Value of Monosomal Karyotype in AML Patients? – Preliminary Results of Retrospective Polish Adult Leukemia Group (PALG) Study,

Blood (2011) 118 (21): 3537.

https://doi.org/10.1182/blood.V118.21.3537.3537

Published: 2011

Journal Articles

Effect of Various Concentrations of Dimethyl Sulfoxide (DMSO) on Cell Recovery and Clonogenic Potential of Cryopreserved Peripheral Blood Hematopoietic Progenitors

Andrzej Smagur, Iwona Mitrus, Sebastian Giebel, Maria Sadus-Wojciechowska, Jacek Najda, Tomasz Kruzel, Tomasz Czerw, Joanna Gliwinska, Magdalena Prokop, Magdalena Glowala-Kosinska, Agata Chwieduk, Jerzy Holowiecki, MD, PhD

Blood (2011) 118 (21): 1930.

https://doi.org/10.1182/blood.V118.21.1930.1930

Published: 2011

Journal Articles

Evaluation of the Toxicity of Total Body Irradation As a Separate Treatment in Preparation for Hematopoietic Cell Transplantation

Sebastian Giebel, MD, Tomasz Kruzel, Maria Sadus-Wojciechowska, MD, Jacek Najda, MD, Tomasz Czerw, MD, Leszek Miszczyk, MD, PhD, Jerzy Holowiecki, MD, PhD

Blood (2011) 118 (21): 4579.

https://doi.org/10.1182/blood.V118.21.4579.4579

Published: 2011

Journal Articles

The Prophylactic Use of G-CSF During Induction and Consolidation of Adults with Acute Lymphoblastic Leukemia Is Associated with Reduced Risk of Relapse and Improved Leukemia-Free Survival. A Joint Analysis of Five Randomized Trials on Behalf of the European Working Group for Adult ALL (EWALL)

Sebastian Giebel, MD, Xavier Thomas, MD, PhD, Helene Hallbook, MD, Klaus Geissler, MD, Jean-Michel Boiron, MD, PhD, Françoise Huguet, MD, Bengt Smedmyr, MD, PhD, Elisabeth Koller, MD, Andrzej Hellmann, MD, Jerzy Holowiecki, MD

Blood (2010) 116 (21): 2130.

https://doi.org/10.1182/blood.V116.21.2130.2130

Published: 2010

Journal Articles

Improved Outcome of Adult Acute Lymphoblastic Leukemia Treated with Individualized Protocol Adjusted to the Status of Minimal Residual Disease and Age. Interim Analysis of PALG ALL 5–2007 Study

Blood (2010) 116 (21): 2138.

https://doi.org/10.1182/blood.V116.21.2138.2138

Published: 2010

Journal Articles

Disparities of Minor Histocompatibility Antigens in Unrelated Allo-HCT.

Miroslaw Markiewicz, MD, Urszula Siekiera, Jerzy Wojnar, MD,PhD, Iwona Wylezol, MD, Sebastian Giebel, MD, Monika Dzierzak, MD, Agnieszka Karolczyk, Jerzy Holowiecki, MD,PhD

Blood (2007) 110 (11): 3070.

https://doi.org/10.1182/blood.V110.11.3070.3070

Published: 2007

Journal Articles

Dasatinib or High-Dose Imatinib for Patients with Chronic-Phase Chronic Myeloid Leukemia Resistant to Standard-Dose Imatinib: 2-Year Follow-Up Data from START-R (CA180-017).

Hagop M. Kantarjian, MD, Philippe Rousselot, MD, Ricardo Pasquini, MD, Nelson Hamerschlak, MD, Jerzy Holowiecki, MD, David Dejardin, Eric Bleickardt, MD, Neil P. Shah, MD

Blood (2007) 110 (11): 736.

https://doi.org/10.1182/blood.V110.11.736.736

Published: 2007

Journal Articles

Beyond HLA: Impact of Immunoreactive Mismatches of Minor Histocompatibility Antigens on Probability of Relapse and Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplantation from HLA-Matched Unrelated Donors.

Miroslaw Markiewicz, MD, PhD, Urszula Siekiera, Dr of Biol Sci, Jerzy Wojnar, MD, Assoc., Agata Wieczorkiewicz, MD, Iwona Wylezol, MD, PhD, Sebastian Giebel, MD, PhD, Agnieszka Karolczyk, Biol., Jerzy Holowiecki, MD

Blood (2006) 108 (11): 3156.

https://doi.org/10.1182/blood.V108.11.3156.3156

Published: 2006

Journal Articles

Fludarabine, Mitoxantrone and Dexametasone in the Treatment of Relapsed and Refractory Low-Grade Non-Hodgkin Lymphoma.

Joanna Sawczuk-Chabin, MD, Ewa Kalinka, MD, PhD, Piotr Centkowski, MD, Katarzyna Budziszewska, MD, PhD, Bernadeta Ceglarek, MD, PhD, Jacek Najda, MD, PhD, Maria Blasinska-Morawiec, MD, PhD, Kazimierz Sulek, MD, PhD, Jerzy Holowiecki, MD, PhD, Lech Konopka, MD, PhD, Krzysztof Warzocha, MD, PhD, for Polish Lymphoma Research Group

Blood (2005) 106 (11): 4738.

https://doi.org/10.1182/blood.V106.11.4738.4738

Published: 2005

Journal Articles

Single Immunophenotypical Evaluation of Minimal Residual Disease before Autotransplantation of Non-Cryopreserved Bone Marrow Is Insufficient for Prediction of Outcome in High Risk Adult Acute Lymphoblastic Leukemia.

Beata M. Stella-Holowiecka, MD, Krystyna Jagoda, MD, Aleksandra M. Holowiecka-Goral, MD, Tomasz Czerw, MD, Sebastian Giebel, MD, Malgorzata Krawczyk-Kulis, MD, Jerzy Holowiecki, MD, PhD

Blood (2004) 104 (11): 4439.

https://doi.org/10.1182/blood.V104.11.4439.4439

Published: 2004

Journal Articles

Treosulfan-Based Myeloablative Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation Is Associated with Reduced Toxicity without Increased Risk of Relapse.

Sebastian Giebel, MD, Jerzy Wojnar, MD, Malgorzata Krawczyk-Kulis, MD, Iwona Wylezol, MD, Miroslaw Markiewicz, MD, Tomasz Kruzel, MD, Jerzy Holowiecki, MD

Blood (2004) 104 (11): 1152.

https://doi.org/10.1182/blood.V104.11.1152.1152

Published: 2004

Journal Articles

Identification of Factors Associated with Poor Hematopoetic Cell Mobilization and Collection from Peripheral Blood in Non-Hodgkin’s Lymphoma; Single Center Analysis of 80 Patients.

Lucja Kachel, MD, Jerzy Holowiecki, MD, Ph.D

Blood (2004) 104 (11): 5010.

https://doi.org/10.1182/blood.V104.11.5010.5010

Published: 2004

NARROW

Increased Efficacy of Chemomobilization with Intermediate Dose Cytarabine + G-CSF Compared to G-CSF Alone for Patients with Multiple Myeloma: Results of a Prospective, Randomized Trial

Cladribine, Cytarabine and Mitoxantrone As Treatment Intensification for Patients with Acute Myeloid Leukemia with the Excess of Bone Marrow Blasts on Day 14 of the First Induction. Prospective, Multicenter Study By the Polish Adult Leukemia Group (PALG)

Cladribine Added to Daunorubicin and Cytarabine Induction Regimen Prolongs Survival of Patients with Complex but Not Monosomal Karyotype Acute Myeloid Leukemia – Retrospective Analysis of Polish Adult Leukemia Group (PALG)

The Aethera Trial: Results of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Brentuximab Vedotin in the Treatment of Patients at Risk of Progression Following Autologous Stem Cell Transplant for Hodgkin Lymphoma

Daunorubicine, Cytarabine and Cladribine (DAC) Vs Daunorubicine and Cytarabine (DA) Induction Treatment in Elderly Acute Myeloid Leukemia (AML) Patients – Results of the Prospective, Multicenter, Randomized Trial of the Polish Adult Leukemia Group (PALG)

Autologous Peripheral Blood Progenitor Cells Cryopreserved in 7.5% DMSO Give Faster Hematopoietic Reconstitution Than Cells Cryopreserved in 10% DMSO.

Very High Efficacy of Stem Cell Mobilization Using Intermadiate-Dose Cytosine Arabinoside + G-CSF in Patients with Lymphoid Malignancies, Including Predicted and Proven Poor Mobilizers

Is Type of Monosomy (Total or Partial) Crucial for Prognostic Value of Monosomal Karyotype in AML Patients? – Preliminary Results of Retrospective Polish Adult Leukemia Group (PALG) Study,

Effect of Various Concentrations of Dimethyl Sulfoxide (DMSO) on Cell Recovery and Clonogenic Potential of Cryopreserved Peripheral Blood Hematopoietic Progenitors

Evaluation of the Toxicity of Total Body Irradation As a Separate Treatment in Preparation for Hematopoietic Cell Transplantation

The Prophylactic Use of G-CSF During Induction and Consolidation of Adults with Acute Lymphoblastic Leukemia Is Associated with Reduced Risk of Relapse and Improved Leukemia-Free Survival. A Joint Analysis of Five Randomized Trials on Behalf of the European Working Group for Adult ALL (EWALL)

Improved Outcome of Adult Acute Lymphoblastic Leukemia Treated with Individualized Protocol Adjusted to the Status of Minimal Residual Disease and Age. Interim Analysis of PALG ALL 5–2007 Study

Disparities of Minor Histocompatibility Antigens in Unrelated Allo-HCT.

Dasatinib or High-Dose Imatinib for Patients with Chronic-Phase Chronic Myeloid Leukemia Resistant to Standard-Dose Imatinib: 2-Year Follow-Up Data from START-R (CA180-017).

Beyond HLA: Impact of Immunoreactive Mismatches of Minor Histocompatibility Antigens on Probability of Relapse and Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplantation from HLA-Matched Unrelated Donors.

Fludarabine, Mitoxantrone and Dexametasone in the Treatment of Relapsed and Refractory Low-Grade Non-Hodgkin Lymphoma.

Single Immunophenotypical Evaluation of Minimal Residual Disease before Autotransplantation of Non-Cryopreserved Bone Marrow Is Insufficient for Prediction of Outcome in High Risk Adult Acute Lymphoblastic Leukemia.

Treosulfan-Based Myeloablative Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation Is Associated with Reduced Toxicity without Increased Risk of Relapse.

Identification of Factors Associated with Poor Hematopoetic Cell Mobilization and Collection from Peripheral Blood in Non-Hodgkin’s Lymphoma; Single Center Analysis of 80 Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only